IP Library › Granted Patent US 11,850,258
Granted Patent B1
US 11,850,258 · App. 16/887,951 · Granted Dec 26, 2023

Ribonucleoside derivatives with 3′-aminoxy groups

Inventors: Nilesh B. Karalkar (Gainesville, FL); Steven A. Benner (Gainesville, FL)
A61K31/708A61K31/7068A61K31/7072A61K31/7076C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,850,258
App. No.
16/887,951
Granted
Dec 26, 2023
Kind
B1
Abstract

This invention claims ribonucleosides and their derivatives, including triphosphates, that have a 3′-ONH 2 moiety instead of a 3′-OH moiety.

Claims (35)

1. A compound having the structure:

or one of its salts, wherein B is a heterocycle selected from the group consisting of

wherein Su indicates the point of attachment of the heterocycle to the sugar, R is either H, CH 3 , or a functionalized side chain, X is either N or C—R, and M is selected from the group consisting of hydrogen, monophosphate, diphosphates, or triphosphate.

2. A composition that comprises an aqueous solution containing a compound having the structure:

or one of its salts, wherein B is a heterocycle selected from the group consisting of

wherein Su indicates the point of attachment of the heterocycle to the sugar, R is either H, CH 3 , or a functionalized side chain, X is either N or C—R, and M is selected from the group consisting of hydrogen, monophosphate, diphosphates, or triphosphate.

3. The composition of claim 2 , wherein said aqueous solution is buffered.

4. The composition of claim 2 , wherein said aqueous solution also contains an enzyme.

5. The composition of claim 4 , wherein said enzyme is a DNA polymerase, and RNA polymerase, a reverse transcriptase, or a terminal transferase.

6. A process for adding to a primer a nucleotide analog, said process comprising contacting said primer in an aqueous solution containing an enzyme and a triphosphate having the structure:

or one of its salts, wherein B is a heterocycle selected from the group consisting of

wherein Su indicates the point of attachment of the heterocycle to the sugar, R is either H, CH 3 , or a functionalized side chain, X is either N or C—R, and M is triphosphate.

7. The process of claim 6 , wherein said enzyme is a DNA polymerase, and RNA polymerase, a reverse transcriptase, or a terminal transferase.

8. A compound having the structure:

or one of its salts, wherein B is a heterocycle selected from the group consisting of

9. The compound of claim 8 , wherein said B heterocycle is selected from the group consisting of

and R is either H or CH 3 .

10. A compound having the structure:

or one of its salts, wherein B is a heterocycle selected from the group consisting of

wherein Su indicates the point of attachment of the heterocycle to the sugar, R is either H, CH 3 , or a functionalized side chain, X is either N or C—R, and M is selected from the group consisting of hydrogen, monophosphate, diphosphates, or triphosphate.

11. The compound of claim 10 , wherein said B heterocycle is selected from the group consisting of

and R is either H or CH 3 .

12. The compound of claim 11 , wherein said B heterocycle is either thymine or uracil.

13. A composition that comprises an aqueous solution containing a compound having the structure:

or one of its salts, wherein B is a heterocycle selected from the group consisting of

wherein Su indicates the point of attachment of the heterocycle to the sugar, R is either H, CH 3 , or a functionalized side chain, X is either N or C—R, and M is selected from the group consisting of hydrogen, monophosphate, diphosphates, or triphosphate.

14. The composition of claim 13 , wherein said B heterocycle is selected from the group consisting of

and R is either H or CH 3 .

15. The composition of claim 13 or claim 14 , wherein said aqueous solution is buffered.

16. The composition of claim 13 or claim 14 , wherein said aqueous solution also contains an enzyme.

17. The composition of claim 16 , wherein said enzyme is a DNA polymerase, and RNA polymerase, a reverse transcriptase, or a terminal transferase.

18. A process for adding to a primer a nucleotide analog, said process comprising contacting said primer in an aqueous solution containing an enzyme and a triphosphate having the structure:

or one of its salts, wherein B is a heterocycle selected from the group consisting of

wherein Su indicates the point of attachment of the heterocycle to the sugar, R is either H, CH 3 , or a functionalized side chain, X is either N or C—R, and M is triphosphate.

19. The process of claim 18 , wherein said enzyme is a DNA polymerase, and RNA polymerase, a reverse transcriptase, or a terminal transferase.

Assignments (3)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 8, 2025
From: BENNER, STEVEN A.; KARALKAR, NILESH B.
To: FOUNDATION FOR APPLIED MOLECULAR EVOLUTION
Reel/Frame 072185/0928 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2025
From: FOUNDATION FOR APPLIED MOLECULAR EVOLUTION
To: FIREBIRD BIOMOLECULAR SCIENCES
Reel/Frame 072186/0075 →
CONFIRMATORY LICENSE Recorded Aug 3, 2020
From: FOUNDATION FOR APPLIED MOLECULAR EVOLUTION INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 053379/0039 →